The Influence of Genetic Variations in CYP1A2 Associated with Clozapine Metabolism in Schizophrenia Patients

Fathina Annajla, Annisa Frastica Septi, Nanda Diva Meilani, Aurora Fatimatuz Zahro

Abstract


Schizophrenia is a severe mental disorder that affects how a person thinks, feels, and behaves. Antipsychotic drugs are the treatment of choice for patients with schizophrenia. Clozapine is an atypical antipsychotic with unique efficacy in treatment-resistant schizophrenia. However, genetic variations in CYP1A2 can influence the differences in the activity of this enzyme, which in turn can affect the metabolism of clozapine and the response to treatment. This review aims to examine the impact of CYP1A2 genetic variations on clozapine metabolism in patients with schizophrenia. This review is prepared using the narrative literature review method, literature search was conducted through PubMed over the past ten years (2014-2024) using relevant keywords. The findings indicate that CYP1A2 genetic variations *1F is an ultrarapid metabolizer whose activity is strengthened by the presence of cigarettes, while *1C and *1D shows a decrease in CYP1A2 enzyme metabolism. This review underscores the importance of considering genetic factors, particularly CYP1A2, in tailoring treatment plans for schizophrenia patients

Keywords


Clozapine; CYP1A2; Polymorphism; Schizophrenia

Full Text:

PDF

References


Ammar, H., Chadli, Z., Mhalla, A., Khouadja, S., Hannachi, I., Alshaikheid, M., Slama, A., Ben Fredj, N., Ben Fadhel, N., Ben Romdhane, H., Chaabane, A., Boughattas, N. A., Gaha, L., Zarrouk, L., & Aouam, K. (2021). Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients. Pharmacogenomics Journal, 21(5), 551–558. https://doi.org/10.1038/s41397-021-00231-x

Brisch, R., Saniotis, A., Wolf, R., Bielau, H., Bernstein, H.-G., Steiner, J., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., Henneberg, M., & Gos, T. (2014). The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue. Frontiers in Psychiatry, 5. https://doi.org/10.3389/fpsyt.2014.00047

Britannica, T. E. of E. (2024). neurotransmitter. Encyclopedia Britannica. https://www.britannica.com/science/neurotransmitter

Caetano, D., & Piatkov, I. (2015). Higher than expected clozapine serum level and clozapine/norclozapine ratio due to CYP450 gene polymorphisms. Personalized Medicine, 12(6), 555–558. https://doi.org/10.2217/pme.15.33

Caetano, D., & Piatkov, I. (2016). Ultrarapid clozapine metabolism and CYP2D6 gene duplication in a patient with schizophrenia. Personalized Medicine, 13(2), 113–117. https://doi.org/10.2217/pme.15.56

Cipta, D. A., & Saputra, A. (2022). Changing Landscape of Mental Health from Early Career Psychiatrists’ Perspective in Indonesia. JoGHNP. https://doi.org/doi:10.52872/001c.37413

de Leon, J., Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppälä, N., Kopeček, M., Švancer, P., Olmos, I., Ricciardi, C., Iglesias-Garcia, C., Iglesias-Alonso, A., Spina, E., Ruan, C.-J., Wang, C.-Y., Wang, G., Tang, Y.-L., Lin, S.-K., Lane, H.-Y., … Müller, D. J. (2022). An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry, 55(02), 73–86. https://doi.org/10.1055/a-1625-6388

Dean, L., & Kane, M. (2012). Clozapine Therapy and CYP Genotype. In Medical Genetics Summaries. http://www.ncbi.nlm.nih.gov/pubmed/26364648

Ford, E. (2020). Tell me your story: Narrative inquiry in LIS research. College & Research Libraries, 81(2), 235–247. https://doi.org/https://doi.org/10.5860/crl.81.2.235

Franciely, H., Vianello, R. P., Galaviz-hernández, C., Sosa-macías, M., & Brito, R. B. De. (2020). The CYP2C19 * 2 and CYP2C19 * 17 Polymorphisms In fl uence Responses to Clozapine for the Treatment of Schizophrenia. 427–432.

Hany, M., Baryiah, R., Rizvi, A., & Chapman, J. (2024). Schizophrenia. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK539864/

Hilker, R., Heleniusd, D., Fagerlund, B., Skytthef, A., Christensenf, K., Werge, T. M., Nordentoft, M., & Glenthøj, B. (2018). Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register. Biological Psychiatry, 83(6), 492–498.

Hollis, C., & Rapoport, J. (2010). Child and adolescent schizophrenia. In D. R. Weinberger & P. J. Harrison (Eds.), Schizophrenia. pp. 24–46. wiley. https://doi.org/https://doi.org/10.1002/9781444327298.ch3

Huang, H. C., Lua, A. C., Wu, L. S. H., Wu, B. J., Lee, S. M., & Liu, C. Z. (2016). Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene 163AC single nucleotide polymorphism. Psychiatric Genetics, 26(4), 172–177. https://doi.org/10.1097/YPG.0000000000000139

Islam, F., Maciukiewicz, M., Freeman, N., Huang, E., Tiwari, A., Mulsant, B. H., Pollock, B. G., Remington, G., Kennedy, J. L., Müller, D. J., & Rajji, T. K. (2021). Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia. In Journal of Psychopharmacology, 35(1), pp. 31–39). https://doi.org/10.1177/0269881120946288

Jaeschke, K., Hanna, F., Ali, S., Chowdhary, N., Dua, T., & Charlson, F. (2021). Global estimates of service coverage for severe mental disorders: findings from the WHO Mental Health Atlas 2017. Glob Ment Health (Camb), 8(e27). https://doi.org/https://doi.org/10.1017/gmh.2021.19

Jibson, M. D. (2023). Second-generation antipsychotic medications: Pharmacology, administration, and side effects. Www.Uptodate.Com ©. https://www.uptodate.com/contents/second-generation-antipsychotic-medications-pharmacology-administration-and-side-effects/print

Kemenkes RI. (2019). Laporan Riskesdas 2018 Nasional. https://repository.badankebijakan.kemkes.go.id/3514/1/Laporan Riskesdas 2018 Nasional.pdf

Lesche, D., Mostafa, S., Everall, I., Pantelis, C., & Bousman, C. A. (2020). Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity. Pharmacogenomics Journal, 20(2), 192–201. https://doi.org/10.1038/s41397-019-0108-y

McGrath, J., Saha, S., Chant, D., & Welham, J. (2008). Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews, 30, 67–76. https://doi.org/10.1093/epirev/mxn001

Mendoza, M. C. N., & Lindenmayer, J.-P. (2009). N-Desmethylclozapine: Is There Evidence for its Antipsychotic Potential? Clinical Neuropharmacology, 32(3), 154–157. https://doi.org/10.1097/WNF.0b013e31818d46f5

Nahdiyin, N. A. (2023). Jurnal Kajian Perpustakaan dan Informasi. Bibliotika, 7(2), 227–239. https://doi.org/http://dx.doi.org/10.17977/um008vi12017p001

Patel, K. R., Cherian, J., Gohil, K., & Atkinson, D. (2014). Schizophrenia: overview and treatment options. P & T : A Peer-Reviewed Journal for Formulary Management, 39(9), 638–645. http://www.ncbi.nlm.nih.gov/pubmed/25210417

Pfeifervan, C. O., der Horst, M. Z., Bousman, C. A., Lin, B., van Eijk, K. R., Ripke, S., Ayhan, Y., Babaoglu, M. O., Bak, M., Alink, W., van Beek, H., Beld, E., Bouhuis, A., Edlinger, M., Erdogan, I. M., Ertuğrul, A., Yoca, G., Everall, I. P., Gö, C., van der Horst, M. Z., … Luykx, J. J. (2022). Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders. Translational Psychiatry, 12(1), 112-122. https://doi.org/10.1038/s41398-022-01884-3

PharmVar. (2017). CYP1A2. PharmVar. https://www.pharmvar.org/gene/CYP1A2

Quednow, B. B., Geyer, M. A., & Halberstadt, A. L. (2020). Serotonin and schizophrenia. Handbook of Behavioral Neuroscience, 31, 711–743. https://doi.org/10.1016/B978-0-444-64125-0.00039-6

Ros, J. E. K., Smallegoor, W., & van der Weide, J. (2005). The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients. Annals of Clinical Biochemistry, 42(3), 216–219. https://doi.org/10.1258/0004563053857798

Ruan, C. J., Wang, C. Y., Tang, Y. L., Lin, S. K., Lee, S. T., Hong, K. S., Rajkumar, A. P., Jacob, K. S., & De Leon, J. (2019). Exploring the Prevalence of Clozapine Phenotypic Poor Metabolizers in 4 Asian Samples: They Ranged Between 2% and 13%. Journal of Clinical Psychopharmacology, 39(6), 644–648. https://doi.org/10.1097/JCP.0000000000001125

Sheffler, Z. M., Reddy, V., & Pillarisetty, L. S. (2024). Physiology, Neurotransmitters. In StatPearls. http://www.ncbi.nlm.nih.gov/pubmed/29893445

Smith, R. L., O’Connell, K., Athanasiu, L., Djurovic, S., Kringen, M. K., Andreassen, O. A., & Molden, E. (2020). Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits. Translational Psychiatry, 10(1), 1–10. https://doi.org/10.1038/s41398-020-00888-1

SNPedia. (2018). CYP1A2. https://www.snpedia.com/index.php/CYP1A2

Sriretnakumar, V., Huang, E., & Müller, D. J. (2015). Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update. Expert Opinion on Drug Metabolism & Toxicology, 11(11), 1709–1731. https://doi.org/10.1517/17425255.2015.1075003

Thorn, C. F., Müller, D. J., Altman, R. B., & Klein, T. E. (2018). PharmGKB summary. Pharmacogenetics and Genomics, 28(9), 214–222. https://doi.org/10.1097/FPC.0000000000000347

Vasudev, K., Choi, Y. H., Norman, R., Kim, R. B., & Schwarz, U. I. (2017). Genetic Determinants of Clozapine-Induced Metabolic Side Effects. Canadian Journal of Psychiatry, 62(2), 138–149. https://doi.org/10.1177/0706743716670128

WHO. (2022). Schizophrenia. World Health Organitation. https://www.who.int/news-room/fact-sheets/detail/schizophrenia




DOI: https://doi.org/10.36987/jpbn.v10i3.6182

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Fathina Annajla, Annisa Frastica Septi, Nanda Diva Meilani, Aurora Fatimatuz Zahro

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Jurnal Pembelajaran dan Biologi Nukleus (JPBN) by LPPM Universitas Labuhanbatu is under a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY - SA 4.0). Official contact: Rivo +6281362238917